argenx to Host Conference Call & Webcast to Report Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
145
argenx to Host Conference Call & Webcast to Report Fourth Quarter Business Update and Full Year 2016 Financial Results on March 15, 2017

8 March 2017                                   Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced it will host a conference call and audio webcast on Wednesday, March 15, 2017 at 3:00 pm CET (10:00 am EDT) to discuss the 2016 financial results, as well as provide a fourth quarter business update.  

To participate in the conference call, please select your phone number below, and use the confirmation code 75576807. The webcast may be accessed on the homepage of the argenx website at www.argenx.com or by clicking here .

A replay of the webcast will also be available on the argenx website .

About argenx argenx a clinical-stage biotechnology company with a deep pipeline of differentiated antibody-based therapies intended for the treatment of severe auto-immune diseases and cancer. We are focused on developing product candidates that are either first-in-class against novel targets or best-in-class against known, but complex, targets to treat diseases with a significant unmet medical need. Our ability to execute on this focus is enabled by our suite of differentiated technologies. Our SIMPLE Antibody TM Platform, based on the powerful llama immune system, allows us to exploit novel and complex targets, and our three antibody engineering technologies enable us to expand the therapeutic index of our product candidates.   www.argenx.com

Dial-In Numbers:

Participant Free Call Dial-In Numbers: UK          0800 694 0257

Participant Standard International Dial-In: UK Standard International           +44 (0) 1452 555 566

Participant UK Local Call Dial-In Numbers: UK          0844 493 3800 UK National Call                0871 700 0345

Participant Local Call Dial-In Numbers: Australia              0290 371 687 Austria                  0192 865 68 Belgium                0817 000 61 Croatia                  0177 766 11 Czech Republic  2288 804 60 Denmark             3272 7625 Finland                 0923 195 187 France                  0176 742 428 Germany             0692 222 3479 Germany             0692 222 4918 Hungary               0618 088 303 India                      0223 098 5304 Ireland                  0143 196 48 Ireland                  0150 601 53 Italy                       0236 008 146 Latvia                    6778 2516 Luxembourg      2088 0695 Netherlands       0207 176 886 New Zealand     0992 917 07 Norway                                2156 3013 Poland                  2230 701 18 Romania              0318 144 957 Russia                   4996 771 036 Slovenia               0160 093 64 South Africa       2110 032 02 Spain                     9141 436 69 Sweden                               0850 336 434 Switzerland        0565 800 007 USA                       1631 510 7498

For further information, please contact:

Joke Comijn, Corporate Communications Manager +32 (0)477 77 29 44 +32 (0)9 243 40 70 info@argenx.com

Beth DelGiacco (US IR) Stern Investor Relations +1 212 362 1200 beth@sternir.com

Forward-looking Statements

The contents of this announcement include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will", or "should", and include statements argenx makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. argenx' actual results may differ materially from those predicted by the forward-looking statements. argenx undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law. "Management's Discussion and Analysis of Financial Condition and Results of Operations"

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

Updated Category News Views 82

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

Continue Reading
Maternal Role in Type 1 Diabetes: A Non-Genetic Angle

Updated Category News Views 6

Unveiling the Maternal Puzzle in Type 1 Diabetes So here's a stumper: how come kids of moms with type 1 diabetes dodge the disease more than kids of dads with it? Simple genes don't account for it, says a study from University of Colorado Anschutz. With nearly 7,000 kids in this research, you'd think they'd find a genetic smoking gun. Nope. It's pointing to something else...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 41

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
O-I Glass Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 101

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Continue Reading
New CEO Aims to Revolutionize Pregnancy Health Sector

Updated Category News Views 125

Revolution Brewing in Pregnancy Health Look, I’ve seen all sorts of execs take on new gigs, but when I hear about an industry veteran like David Stern stepping in as CEO at Mirvie, I sit up and take notice. It’s not just another leadership shuffle; it’s a potential game-changer for a slice of healthcare that’s long been due for an overhaul. Stern’s got a track...

Continue Reading
Yiddish Prescription Labels Extend Language Access in NY

Updated Category News Views 48

Here's something that might fly under the radar unless you're really in tune with how language impacts healthcare—RxTran's move to include Yiddish on prescription labels might not be rocking financial markets, but it's got a punchy little implication for those of us watching where healthcare intersects with real-world needs. A Push Toward Accessibility Healthcare...

Continue Reading
AppLovin Faces Fraud Lawsuit, Investors Alerted

Updated Category News Views 57

AppLovin's Lawsuit: A Wake-Up Call for Investors The market never forgets, even if some investors might wish reality wasn’t so harsh. On the chopping block this time is AppLovin Corporation (NASDAQ: APP). Seems like their fairy tale with AI turned into a courtroom drama, one that’s throwing a real curveball on those rosy earnings expectations. What's the Case All...

Continue Reading
FFR Schedules Q3 2026 Earnings Call for November 12

Updated Category News Views 104

FFR: On The Edge of Q3 2026 Results Ah, another quarter chock-full of intrigue over at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR). With their third quarter financial results dropping on November 12, anxious investors are waiting to see some solid numbers amid the clouds of optimistic chatters. Nothing gets the heart racing for us seasoned stock folks like an upcoming...

Continue Reading
Unveiling Federal Credit Lab: A Platform Revolution

Updated Category News Views 22

Navigating the Maze of Federal Lending Well, folks, in the tangled web of federal economics, there's a new player aiming to bring some much-needed clarity. Lafayette Square Institute and the Center for USA Lending have rolled out the Federal Credit Lab. Think of it as a treasure trove of data and insights on federal credit, set to become a trusty compass for policymakers,...

Continue Reading
Slim Chickens Redefines TV Dinners with Smart TV Orders

Updated Category News Views 147

Slim Chickens Takes Over Your Living Room Folks, it looks like the couch just became a whole lot more than a place to binge-watch shows. Slim Chickens is shaking things up by letting you order your favorite wings and tenders right from the Samsung Smart TV home screen in Northwest Arkansas. This hell of a move takes fast-casual dining to a whole new level, mixing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Staying Informed: NET Power, Inc. Class Action Update

Updated Category News Views 116

Understanding the NET Power, Inc. Class Action In the realm of investment, class action lawsuits can have significant implications for shareholders, particularly in companies like NET Power, Inc. This lawsuit, initiated by Levi & Korsinsky, LLP, highlights critical information every investor should be aware of concerning their stakes in NET Power. Class Action Lawsuit...

Continue Reading
Pandora's Resilient Growth Amid Economic Challenges

Updated Category News Views 196

Financial Performance Overview Pandora continues to show resilience, achieving an impressive 8% organic growth in their recent quarter. Despite facing economic turbulence, including pressures from foreign exchange rates, tariffs, and changing commodity prices, the brand managed to sustain strong revenue and profit margins. Organic Growth Insights In the recent quarterly...

Continue Reading
Heineken N.V. Shares Buyback Program: Latest Updates

Updated Category News Views 294

Heineken N.V. Shares Buyback Program Overview Heineken N.V. is making notable strides in its current share buyback program, intensifying efforts to strengthen shareholder value while showcasing the company's commitment to sustained growth. The beverage giant has embarked on a significant initiative, pledging €1.5 billion to enhance its market position and boost investor...

Continue Reading
TCL SunPower Global: Leading the Charge for Solar Innovation

Updated Category News Views 309

TCL SunPower Global: A New Era in Solar Energy TCL SunPower Global has emerged as a groundbreaking entity within the TCL Group, dedicated to providing innovative solar energy solutions and redefining sustainable living. With a robust foundation built on 40 years of expertise, this venture is poised to lead the solar energy revolution, addressing the growing demand for...

Continue Reading
Coleridge Initiative Secures USDA Funding for Data Services

Updated Category News Views 74

Coleridge Initiative Receives Significant Funding from USDA The Coleridge Initiative has recently been awarded a contract worth up to $7.5 million by the U.S. Department of Agriculture (USDA). This funding is aimed at establishing a secure data enclave service that will greatly facilitate research and collaborative efforts across various sectors. The Importance of Secure...

Continue Reading